10x Genomics Common Stock Net 2018-2025 | TXG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

10x Genomics common stock net from 2018 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

10x Genomics common stock net from 2018 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$45.2B
Doximity (DOCS)	$11.6B
Hims & Hers Health (HIMS)	$11.2B
Tempus AI (TEM)	$10.5B
IRhythm Technologies (IRTC)	$4.3B
Inspire Medical Systems (INSP)	$3.8B
Hinge Health (HNGE)	$3.6B
Privia Health (PRVA)	$2.5B
Enovis (ENOV)	$1.8B
Schrodinger (SDGR)	$1.6B
Phreesia (PHR)	$1.5B
Clover Health Investments (CLOV)	$1.5B
Azenta (AZTA)	$1.5B
Evolent Health (EVH)	$1.3B
Omnicell (OMCL)	$1.3B
Claritev (CTEV)	$733M
Fulgent Genetics (FLGT)	$552M
Veradigm (MDRX)	$531M
Standard BioTools (LAB)	$475M
Butterfly Network (BFLY)	$457M
Talkspace (TALK)	$422M
TruBridge (TBRG)	$328M
Outset Medical (OM)	$312M
Nyxoah SA (NYXH)	$282M
Health Catalyst (HCAT)	$261M
SOPHiA GENETICS SA (SOPH)	$250M
CapsoVision (CV)	$218M
Zepp Health (ZEPP)	$206M
KORU Medical Systems (KRMD)	$152M
American Well (AMWL)	$126M